Onride 4 mg/5 ml (Oral Solution)
50 ml bottle: ৳ 50.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Ondansetron |
| Company | Medicon pharmaceuticals ltd |
| Also available as |
Title
- Onride Oral Soluble Film
Category
- Medicine
- Pharmaceutical
Description
- An orally dissolving film designed to be applied on top of the tongue where it will dissolve within 20 seconds and then is swallowed with saliva
Function
- Prevention of nausea and vomiting associated with chemotherapy
- Prevention and treatment of post-operative nausea and vomiting
- Prevention of radiotherapy-induced nausea and vomiting
Active Ingredient
- Ondansetron base
Molecular Weight
- 293.3
Dosage Form
- Oral Soluble Film
- Tablet
- Orodispersible Tablet
- Injection
- Oral Solution
Dosage Instructions
- Adults, Pediatric patients (6 months to 18 years)
- Adults
- Pediatric patients (4-11 years)
- Pediatrics (>40 kg)
- Pediatrics (40 kg)
Dosage Adjustment
- For Patients With Impaired Renal Function
- For Patients With Impaired Hepatic Function
- 4 years of age or younger
- Over the age of 65
Pharmacological Action
- Selective blocking agent of the serotonin 5-HT3 receptor type
Administration Instructions
- Tear the pouch carefully along with the edge tear mark
- Put the film on top of your tongue
- Swallow after the film dissolves
- Wash your hands after taking the film
Interactions
- Metabolized by hepatic cytochrome P-450 drug-metabolizing enzymes
- Inducers or inhibitors of these enzymes may change the clearance and half-life
Contraindications
- Hypersensitivity to the drug or any of its components
- Concomitant use of apomorphine
Side Effects
- Headache
- Constipation
- Diarrhea
- Rash
- Sensation of flushing or warmth
- Hiccups
- Liver enzyme abnormalities
- Anaphylaxis
- Bronchospasm
- Tachycardia
- Angina (chest pain)
- Hypokalemia
- Shortness of breath
Pregnancy & Lactation
- No evidence of impaired fertility or harm to the fetus in animal studies
- Excreted in the breast milk of rats
- Caution should be exercised when administered to a nursing women
Precautions & Warnings
- Hypersensitivity reactions reported in patients hypersensitive to other selective 5-HT3 receptor antagonists
- Not to be used in place of nasogastric suction
- May mask a progressive ileus and/or gastric distension
Special Populations
- Dosage adjustment for patients with impaired renal function
- Dosage adjustment for patients with impaired hepatic function
- Little information available about dosage in pediatric patients 4 years of age or younger
- No dosage adjustment needed in patients over the age of 65
Therapeutic Class
- Anti-emetic drugs
Storage Conditions
- Store at temperature not exceeding 30°C in a dry place
- Protect from light and moisture